Common stock, par value $0.0001 per share
- Symbol
- ALUR
- Exchange
- NYSE
- Classification
- COMMON
Current Report · Items 2.02, 9.01 · 8-K
Item 2.02 Results of Operations and Financial Condition. On January 12, 2026, Allurion Technologies, Inc. issued a press release announcing selected preliminary financial results for the quarter and year ended December 31, 2025. The full text of that press release is attached to this Current Report on Form 8-K as Exhibit 99.1 and is incorporated herein by reference.…
Press release in this filing
Allurion Announces Preliminary Fourth Quarter and Full-Year 2025 Results →Allurion is a pioneer in metabolically healthy weight loss. The Allurion Program is a weight-loss platform that combines the Allurion Smart Capsule, the world’s first and only swallowable, ProcedurelessTM gastric balloon for weight loss, the Allurion Virtual Care Suite, including the Allurion Mobile App for consumers and Allurion Insights for healthcare providers featuring the Iris AI Platform, and the Allurion Connected Scale. The Allurion Virtual Care Suite is also available to providers separately from the Allurion Program to help customize, monitor, and manage weight-loss therapy for patients regardless of their treatment plan. The Allurion Smart Capsule is an investigational device in the United States.
Allurion Technologies, Inc. · 8-K · Filed 2026-01-12
Exhibit 99.1 Allurion Announces Preliminary Fourth Quarter and Full-Year 2025 Results Strong quarter-over-quarter revenue growth with continued, substantial improvement in operating expenses and operating loss NATICK, Mass. - January 12, 2026 - Allurion Technologies, Inc. (NYSE: ALUR), a pioneer in metabolically healthy weight loss, today announced preliminary, unaudited results for the fourth quarter and full year 2025. Management expects preliminary, unaudited results for the period as follows: • Fourth quarter revenue of $3.3 million to $3.7 million, a 22% to 37% increase quarter-over-quarter, and full-year revenue of approximately $15 million • Substantial improvement in operating expenses and operating loss quarter-over-quarter and as compared to prior year “We are pleased with our results from the fourth quarter, where we grew revenue meaningfully quarter-over-quarter for the first time in more than one year as our new commercial strategy implemented after our strategic pivot in 2025 began to take hold,” said Dr. Shantanu Gaur, Founder and Chief Executive Officer. “We have also continued to reduce our operating losses through a sharpening of our strategic focus, and, wi…
Open exhibit ↗